These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20932268)

  • 1. Homocysteine, cardiovascular inflammation, and myocardial remodeling.
    Finch JM; Joseph J
    Cardiovasc Hematol Disord Drug Targets; 2010 Dec; 10(4):241-5. PubMed ID: 20932268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
    Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causes of hyperhomocysteinemia and its pathological significance.
    Kim J; Kim H; Roh H; Kwon Y
    Arch Pharm Res; 2018 Apr; 41(4):372-383. PubMed ID: 29552692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies.
    Sharma P; Senthilkumar RD; Brahmachari V; Sundaramoorthy E; Mahajan A; Sharma A; Sengupta S
    Lipids Health Dis; 2006 Jan; 5():1. PubMed ID: 16430779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updating the relationship between hyperhomocysteinemia lowering therapy and cardiovascular events.
    Cheng X
    Cardiovasc Ther; 2013 Aug; 31(4):e19-26. PubMed ID: 23082962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine and cardiovascular disease.
    Kalra DK
    Curr Atheroscler Rep; 2004 Mar; 6(2):101-6. PubMed ID: 15023293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine and cardiovascular disease: current evidence and future prospects.
    Mangoni AA; Jackson SH
    Am J Med; 2002 May; 112(7):556-65. PubMed ID: 12015248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinemia, malnutrition, and inflammation in ESRD patients.
    Suliman ME; Stenvinkel P; Bárány P; Rashid Qureshi A; Lindholm B
    Semin Nephrol; 2006 Jan; 26(1):14-9. PubMed ID: 16412819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The controversial role of B-vitamins in cardiovascular risk: An update.
    Ntaios G; Savopoulos C; Grekas D; Hatzitolios A
    Arch Cardiovasc Dis; 2009 Dec; 102(12):847-54. PubMed ID: 19963194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of homocysteine and heart failure.
    Herrmann M; Taban-Shomal O; Hübner U; Böhm M; Herrmann W
    Eur J Heart Fail; 2006 Oct; 8(6):571-6. PubMed ID: 16504575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate and homocysteine.
    Young IS; Woodside JV
    Curr Opin Clin Nutr Metab Care; 2000 Nov; 3(6):427-32. PubMed ID: 11085827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of hyperhomocysteinaemia in cardiovascular disease.
    Lievers KJ; Kluijtmans LA; Blom HJ
    Ann Clin Biochem; 2003 Jan; 40(Pt 1):46-59. PubMed ID: 12542910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Interaction between Arachidonic Acid Metabolism and Homocysteine.
    Domi E; Hoxha M; Hoxha B; Zappacosta B
    Endocr Metab Immune Disord Drug Targets; 2021; 21(7):1232-1241. PubMed ID: 32888285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine in cardiovascular disease: a culprit or an innocent bystander?
    Kothekar MA
    Indian J Med Sci; 2007 Jun; 61(6):361-71. PubMed ID: 17558103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quo vadis: whither homocysteine research?
    Joseph J; Handy DE; Loscalzo J
    Cardiovasc Toxicol; 2009 Jun; 9(2):53-63. PubMed ID: 19484390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhomocysteinemia and cardiovascular risks in hemodialysis patients.
    Sagheb MM; Ostovan MA; Sohrabi Z; Atabati E; Raisjalai GA; Roozbeh J
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):863-6. PubMed ID: 20814121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine lowering and cardiovascular disease risk: lost in translation.
    Marcus J; Sarnak MJ; Menon V
    Can J Cardiol; 2007 Jul; 23(9):707-10. PubMed ID: 17622392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular oxidant stress and inflammation in hyperhomocysteinemia.
    Papatheodorou L; Weiss N
    Antioxid Redox Signal; 2007 Nov; 9(11):1941-58. PubMed ID: 17822365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine enriched diet leads to prolonged QT interval and reduced left ventricular performance in telemetric monitored mice.
    Rosenberger D; Gargoum R; Tyagi N; Metreveli N; Sen U; Maldonado C; Tyagi S
    Nutr Metab Cardiovasc Dis; 2011 Jul; 21(7):492-8. PubMed ID: 20227264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.